Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Cullinan Therapeutics, Inc.(CGEM) | 7,648,268 | 9,731,341 | +2,083,073 | $108.68M | $177.21M | 10.81% | +$68.53M |
| Aktis Oncology, Inc.01021M104(AKTS) | 4,835,872 | 4,835,872 | 0 | $86.51M | $155.86M | 9.50% | +$69.35M |
| Liquidia Corporation53635D202(LQDA) | 1,405,158 | 1,386,174 | -18,984 | $53.03M | $110.52M | 6.74% | +$57.49M |
| Revolution Medicines, Inc.76155X100(RVMD) | 506,776 | 492,483 | -14,293 | $49.28M | $92.23M | 5.62% | +$42.95M |
| Corcept Therapeutics Incorporated(CORT) | 985,700 | 771,028 | -214,672 | $39.73M | $67.04M | 4.09% | +$27.31M |
| Edgewise Therapeutics, Inc.28036F105(EWTX) | 1,660,696 | 1,620,780 | -39,916 | $52.31M | $65.85M | 4.02% | +$13.54M |
| Travere Therapeutics, Inc.89422G107(TVTX) | 1,133,365 | 1,122,731 | -10,634 | $33.67M | $63.78M | 3.89% | +$30.11M |
| DBV Technologies S.A.23306J309(DBVT) | 5,213,361 | 3,666,284 | -1,547,077 | $108.91M | $60.13M | 3.67% | -$48.78M |
| Trevi Therapeutics, Inc.89532M101(TRVI) | 3,298,430 | 3,073,577 | -224,853 | $39.35M | $57.32M | 3.50% | +$17.97M |
| Alumis Inc | 2,386,529 | 2,019,020 | -367,509 | $52.58M | $56.82M | 3.46% | +$4.24M |
| uniQure N.V.N90064101(QURE) | 1,369,231 | 1,225,855 | -143,376 | $22.39M | $56.46M | 3.44% | +$34.08M |
| Ultragenyx Pharmaceutical Inc.90400D108(RARE) | 0 | 1,418,215 | +1,418,215 | $0 | $47.35M | 2.89% | +$47.35M |
| Relay Therapeutics, Inc.75943R102(RLAY) | 2,359,586 | 2,415,672 | +56,086 | $23.48M | $45.20M | 2.76% | +$21.72M |
| ABIVAX Société Anonyme00370M103(ABVX) | 107,268 | 336,347 | +229,079 | $11.94M | $44.82M | 2.73% | +$32.88M |
| Dyne Therapeutics, Inc.26818M108(DYN) | 1,408,152 | 1,922,093 | +513,941 | $25.53M | $42.69M | 2.60% | +$17.16M |
| Dianthus Therapeutics, Inc.(DNTH) | 423,982 | 420,002 | -3,980 | $35.58M | $40.94M | 2.50% | +$5.36M |
| BioAge Labs, Inc.09077V100(BIOA) | 0 | 1,667,661 | +1,667,661 | $0 | $40.87M | 2.49% | +$40.87M |
| UroGen Pharma Ltd.M96088105(URGN) | 943,803 | 933,415 | -10,388 | $16.97M | $34.35M | 2.09% | +$17.38M |
| MoonLake Immunotherapeutics61559X104(MLTX) | 1,811,082 | 1,606,967 | -204,115 | $33.76M | $31.29M | 1.91% | -$2.47M |
| Palvella Therapeutics, Inc.(PVLA) | 206,404 | 204,027 | -2,377 | $25.73M | $31.18M | 1.90% | +$5.45M |
| Taysha Gene Therapies, Inc.(TSHA) | 0 | 4,500,000 | +4,500,000 | $0 | $30.64M | 1.87% | +$30.64M |
| Syndax Pharmaceuticals, Inc.87164F105(SNDX) | 1,340,733 | 1,333,523 | -7,210 | $31.32M | $29.15M | 1.78% | -$2.17M |
| Monte Rosa Therapeutics, Inc.61225M102(GLUE) | 1,176,928 | 1,161,081 | -15,847 | $19.36M | $28.10M | 1.71% | +$8.74M |
| Zura Bio LimitedG9TY5A101(ZURA) | 0 | 4,472,843 | +4,472,843 | $0 | $26.39M | 1.61% | +$26.39M |
| Natera, Inc.(NTRA) | 93,074 | 92,638 | -436 | $18.61M | $25.15M | 1.53% | +$6.53M |
| Stoke Therapeutics, Inc.86150R107(STOK) | 767,038 | 723,314 | -43,724 | $24.97M | $23.67M | 1.44% | -$1.31M |
| Adlai Nortye Group Ltd.00704R109(ANL) | 0 | 1,936,291 | +1,936,291 | $0 | $22.27M | 1.36% | +$22.27M |
| Belite Bio, Inc07782B104(BLTE) | 88,045 | 137,208 | +49,163 | $14.04M | $21.13M | 1.29% | +$7.09M |
| Forte Biosciences, Inc.34962G208 | 1,000,682 | 987,448 | -13,234 | $25.92M | $20.98M | 1.28% | -$4.93M |
| ORIC Pharmaceuticals, Inc.68622P109(ORIC) | 1,803,945 | 1,882,162 | +78,217 | $22.86M | $20.38M | 1.24% | -$2.47M |
| Tarsus Pharmaceuticals, Inc.87650L103(TARS) | 329,750 | 322,007 | -7,743 | $23.13M | $20.27M | 1.24% | -$2.86M |
| Annexon, Inc.03589W102(ANNX) | 0 | 3,544,354 | +3,544,354 | $0 | $20.24M | 1.23% | +$20.24M |
| Bright Minds Biosciences Inc.10919W405(DRUG) | 212,175 | 202,114 | -10,061 | $15.48M | $14.19M | 0.87% | -$1.29M |
| Entrada Therapeutics, Inc.29384C108(TRDA) | 0 | 1,253,053 | +1,253,053 | $0 | $9.22M | 0.56% | +$9.22M |
| Aclaris Therapeutics, Inc.00461U105(ACRS) | 391,918 | 1,042,467 | +650,549 | $1.47M | $5.51M | 0.34% | +$4.04M |
| Context Therapeutics Inc.21077P108(CNTX) | 10,679,391 | 1,299,046 | -9,380,345 | $27.98M | $719.5K | 0.04% | -$27.26M |
| Werewolf Therapeutics, Inc.95075A107(HOWL) | 1,208,810 | 80,142 | -1,128,668 | $1.01M | $28.9K | 0.00% | -$977.6K |
| Agios Pharmaceuticals, Inc.(AGIO) | 1,306,261 | 0 | -1,306,261 | $44.19M | $0 | — | -$44.19M |
| Allogene Therapeutics, Inc. | 2,242,933 | 0 | -2,242,933 | $5.47M | $0 | — | -$5.47M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 733,966 | 0 | -733,966 | $17.29M | $0 | — | -$17.29M |
| Climb Bio, Inc.(CLYM) | 2,593,439 | 0 | -2,593,439 | $17.77M | $0 | — | -$17.77M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 1,674,875 | 0 | -1,674,875 | $24.50M | $0 | — | -$24.50M |
| Cytokinetics, Incorporated(CYTK) | 500,000 | 0 | -500,000 | $32.95M | $0 | — | -$32.95M |
| enGene Holdings, Inc. COM | 1,845,373 | 0 | -1,845,373 | $12.57M | $0 | — | -$12.57M |
| Evommune, Inc.(EVMN) | 1,455,863 | 0 | -1,455,863 | $33.47M | $0 | — | -$33.47M |
| Viridian Therapeutics, Inc.(VRDN) | 649,873 | 0 | -649,873 | $12.71M | $0 | — | -$12.71M |
| Xenon Pharmaceuticals Inc.(XENE) | 588,706 | 0 | -588,706 | $34.23M | $0 | — | -$34.23M |
| Zymeworks Inc.(ZYME) | 565,249 | 0 | -565,249 | $14.15M | $0 | — | -$14.15M |